{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T23:40:42Z","timestamp":1768520442021,"version":"3.49.0"},"reference-count":40,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T00:00:00Z","timestamp":1608076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and objectives: To compare the diagnostic accuracy and clinical utility of the Early-stage Ovarian Malignancy (EOM) score with the Risk of Malignancy Index (RMI) in the presurgical assessment of women presenting with adnexal masses. Materials and Methods: A secondary analysis was carried out in a retrospective cohort of women who presented with an adnexal mass and were scheduled for surgery at Phrapokklao Hospital between September 2013 and December 2017. The clinical characteristics, ultrasonographic features of the masses, and preoperative CA-125 levels were recorded. The EOM and the RMI score were calculated and compared in terms of accuracy and clinical utility. Decision curve analysis (DCA), which examined the net benefit (NB) of applying the EOM and the RMI in practice at a range of threshold probabilities, was presented. Results: In this study, data from 270 patients were analyzed. Fifty-four (20.0%) women in the sample had early-stage ovarian cancer. All four RMI versions demonstrated a lower sensitivity for the detection of patients with early-stage ovarian cancer compared to an EOM score \u2265 15. An EOM \u2265 15 resulted in a higher proportion of net true positive or NB than all versions of the RMIs from a threshold probability of 5% to 30%. Conclusions: It also showed a higher capability to reduce the number of inappropriate referrals than the RMIs at a threshold probability between 5% and 30%. The EOM score showed higher diagnostic sensitivity and has the potential to be clinically more useful than the RMIs to triage women who present with adnexal masses for referral to oncologic gynecologists. Further external validation is required to support our findings.<\/jats:p>","DOI":"10.3390\/medicina56120702","type":"journal-article","created":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T09:21:15Z","timestamp":1608110475000},"page":"702","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Early-Stage Ovarian Malignancy Score versus Risk of Malignancy Indices: Accuracy and Clinical Utility for Preoperative Diagnosis of Women with Adnexal Masses"],"prefix":"10.3390","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8543-6254","authenticated-orcid":false,"given":"Phichayut","family":"Phinyo","sequence":"first","affiliation":[{"name":"Department of Family Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayanton","family":"Patumanond","sequence":"additional","affiliation":[{"name":"Center for Clinical Epidemiology and Clinical Statistics, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panprapha","family":"Saenrungmuaeng","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, Mahasarakham University, Maha Sarakham 44150, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Watcharin","family":"Chirdchim","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Phrapokklao Hospital, Chanthaburi 22000, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7154-5671","authenticated-orcid":false,"given":"Tanyong","family":"Pipanmekaporn","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apichat","family":"Tantraworasin","sequence":"additional","affiliation":[{"name":"Department of Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3389-6478","authenticated-orcid":false,"given":"Theera","family":"Tongsong","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1343-0782","authenticated-orcid":false,"given":"Charuwan","family":"Tantipalakorn","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,12,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/uog.12323","article-title":"Improving strategies for diagnosing ovarian cancer: A summary of the International Ovarian Tumor Analysis (IOTA) studies","volume":"41","author":"Kaijser","year":"2013","journal-title":"Ultrasound Obs. Gynecol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1046\/j.0960-7692.2001.00500.x","article-title":"Comparison of \u2018pattern recognition\u2019 and logistic regression models for discrimination between benign and malignant pelvic masses: A prospective cross validation","volume":"18","author":"Valentin","year":"2001","journal-title":"Ultrasound Obs. Gynecol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.ygyno.2007.02.030","article-title":"The outcomes of ovarian cancer treatment are better when provided by gynecologic oncologists and in specialized hospitals: A systematic review","volume":"105","author":"Vernooij","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"ref_4","first-page":"12","article-title":"Optimal primary surgical treatment for advanced epithelial ovarian cancer","volume":"2011","author":"Elattar","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"5082","DOI":"10.1158\/1078-0432.CCR-16-3248","article-title":"Clinical Utility of Risk Models to Refer Patients with Adnexal Masses to Specialized Oncology Care: Multicenter External Validation Using Decision Curve Analysis","volume":"23","author":"Wynants","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_6","first-page":"5","article-title":"Centralisation of services for gynaecological cancer","volume":"2012","author":"Woo","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"American College of Obstetricians and Gynecologists (2016). Practice Bulletin No. 174: Evaluation and Management of Adnexal Masses. Obstet Gynecol., 128, e210.","DOI":"10.1097\/AOG.0000000000001768"},{"key":"ref_8","unstructured":"National Collaborating Centre for Cancer (UK) (2011). Ovarian Cancer The Recognition and Initial Management of Ovarian Cancer; National Institute for Health and Clinical Excellence: Guidance; National Collaborating Centre for Cancer (UK), National Collaborating Centre for Cancer (UK)."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/humupd\/dmt059","article-title":"Presurgical diagnosis of adnexal tumours using mathematical models and scoring systems: A systematic review and meta-analysis","volume":"20","author":"Kaijser","year":"2014","journal-title":"Hum. Reprod. Updat."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/ijgo.12891","article-title":"Comparison of the diagnostic accuracy of International Ovarian Tumor Analysis simple rules and the risk of malignancy index to discriminate between benign and malignant adnexal masses","volume":"146","author":"Auekitrungrueng","year":"2019","journal-title":"Int. J. Gynecol. Obs."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s13224-019-01229-z","article-title":"IOTA Simple Ultrasound Rules for Triage of Adnexal Mass: Experience from South India","volume":"69","author":"Shetty","year":"2019","journal-title":"J. Obs. Gynecol. India"},{"key":"ref_12","first-page":"3695","article-title":"The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma","volume":"63","author":"Raycraft","year":"2003","journal-title":"Cancer Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1136\/jcp.2004.018077","article-title":"The role of CA125 in clinical practice","volume":"58","author":"Moss","year":"2005","journal-title":"J. Clin. Pathol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/IGC.0b013e31828f7a24","article-title":"CA-125 Level as a Prognostic Indicator in Type I and Type II Epithelial Ovarian Cancer","volume":"23","author":"Chen","year":"2013","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/1096-9098(200012)75:4<264::AID-JSO7>3.0.CO;2-Q","article-title":"Benign conditions associated with raised serum CA-125 concentration","volume":"75","author":"Buamah","year":"2000","journal-title":"J. Surg. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ygyno.2016.11.019","article-title":"CONCORD Working Group Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)","volume":"144","author":"Matz","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1749-6632.2002.tb02761.x","article-title":"The epidemiology of endometriosis","volume":"955","author":"Cramer","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_18","first-page":"163","article-title":"Evaluation of Four Risk of Malignancy Indices (RMI) in the Preoperative Diagnosis of Ovarian Malignancy at Rajavithi Hospital","volume":"201","author":"Insin","year":"2013","journal-title":"Thai J. Obstet. Gynaecol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/j.1471-0528.1990.tb02448.x","article-title":"A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer","volume":"97","author":"Jacobs","year":"1990","journal-title":"BJOG"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1471-0528.1996.tb09882.x","article-title":"Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre-operative diagnosis of pelvic masses","volume":"103","author":"Tingulstad","year":"1996","journal-title":"BJOG"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/00006250-199903000-00028","article-title":"The Risk-of-Malignancy Index to Evaluate Potential Ovarian Cancers in Local Hospitals","volume":"93","author":"Tingulstad","year":"1999","journal-title":"Obs. Gynecol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejogrb.2009.02.048","article-title":"Comparison of four malignancy risk indices in the preoperative evaluation of patients with pelvic masses","volume":"144","author":"Yamamoto","year":"2009","journal-title":"Eur. J. Obs. Gynecol. Reprod. Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.31557\/APJCP.2019.20.4.1207","article-title":"Development and Validation of a Predictive Score for Preoperative Diagnosis of Early Stage Epithelial Ovarian Cancer","volume":"20","author":"Chirdchim","year":"2019","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.2214\/AJR.15.15199","article-title":"Ovarian Cancer, the Revised FIGO Staging System, and the Role of Imaging","volume":"206","author":"Javadi","year":"2016","journal-title":"Am. J. Roentgenol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejca.2016.07.015","article-title":"The impact of lymph node dissection and adjuvant chemotherapy on survival: A nationwide cohort study of patients with clinical early-stage ovarian cancer","volume":"66","author":"Kleppe","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1600-0412.2012.01359.x","article-title":"Danish \u2018Pelvic Mass\u2019 Ovarian Cancer Study Risk of malignancy index used as a diagnostic tool in a tertiary centre for patients with a pelvic mass","volume":"91","author":"Nedergaard","year":"2012","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/0272989X06295361","article-title":"Decision Curve Analysis: A Novel Method for Evaluating Prediction Models","volume":"26","author":"Vickers","year":"2006","journal-title":"Med. Decis. Mak."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.eururo.2018.08.038","article-title":"Reporting and Interpreting Decision Curve Analysis: A Guide for Investigators","volume":"74","author":"Wynants","year":"2018","journal-title":"Eur. Urol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"i6","DOI":"10.1136\/bmj.i6","article-title":"Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests","volume":"352","author":"Vickers","year":"2016","journal-title":"BMJ"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/bjc.2014.333","article-title":"Strategies to diagnose ovarian cancer: New evidence from phase 3 of the multicentre international IOTA study","volume":"111","author":"Testa","year":"2014","journal-title":"Br. J. Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s41512-019-0064-7","article-title":"A simple, step-by-step guide to interpreting decision curve analysis","volume":"3","author":"Vickers","year":"2019","journal-title":"Diagn. Progn. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.tjog.2014.05.002","article-title":"The risk of malignancy index (RMI) in women with adnexal masses in Wales","volume":"53","author":"Abdulrahman","year":"2014","journal-title":"Taiwan J. Obs. Gynecol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1471-0528.1999.tb08318.x","article-title":"Comparison of two malignancy risk indices based on serum CA125, ultrasound score and menopausal status in the diagnosis of ovarian masses","volume":"106","author":"Morgante","year":"1999","journal-title":"BJOG"},{"key":"ref_34","first-page":"865","article-title":"The risk of malignancy index (RMI) in diagnosis of ovarian malignancy","volume":"10","author":"Moolthiya","year":"2009","journal-title":"APJCP"},{"key":"ref_35","first-page":"815","article-title":"External Validation of Diagnostic Models to Estimate the Risk of Malignancy in Adnexal Masses","volume":"18","author":"Bourne","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/jama.2015.37","article-title":"Decision Curve Analysis","volume":"313","author":"Fitzgerald","year":"2015","journal-title":"JAMA"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Froyman, W., Wynants, L., Landolfo, C., Bourne, T., Valentin, L., Testa, A.C., Sladkevicius, P., Franchi, D., Fischerova, D., and Savelli, L. (2017). Validation of the Performance of International Ovarian Tumor Analysis (IOTA) Methods in the Diagnosis of Early Stage Ovarian Cancer in a Non-Screening Population. Diagnostics, 7.","DOI":"10.3390\/diagnostics7020032"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.ejca.2009.12.012","article-title":"Understanding the problem of inadequately staging early ovarian cancer","volume":"46","author":"Timmers","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.bpobgyn.2016.10.001","article-title":"Surgical treatment of early-stage ovarian cancer","volume":"41","author":"Trimbos","year":"2017","journal-title":"Best Pract. Res. Clin. Obs. Gynaecol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Bristow, R.E., Karlan, B.Y., and Chi, D.S. (2010). Surgery for Ovarian Cancer: Principles and Practice, CRC Press.","DOI":"10.3109\/9781841847825"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/56\/12\/702\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:45:36Z","timestamp":1760179536000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/56\/12\/702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,16]]},"references-count":40,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["medicina56120702"],"URL":"https:\/\/doi.org\/10.3390\/medicina56120702","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,16]]}}}